These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9145707)

  • 41. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
    Setoguchi S; Glynn RJ; Avorn J; Mittleman MA; Levin R; Winkelmayer WC
    J Am Coll Cardiol; 2008 Apr; 51(13):1247-54. PubMed ID: 18371553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Multi-drug management after myocardial infarct].
    Kritz H; Sinzinger H
    Wien Klin Wochenschr; 1997; 109 Suppl 2():17-24. PubMed ID: 9340918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Drug therapy as secondary prevention following myocardial infarction].
    Cottier C
    Praxis (Bern 1994); 1996 Apr; 85(17):545-7. PubMed ID: 8668892
    [No Abstract]   [Full Text] [Related]  

  • 44. Beta blockers and calcium channel blocking agents in acute myocardial infarction.
    Pearle DL; Rackley CE
    Cardiovasc Clin; 1986; 16(3):29-38. PubMed ID: 2875793
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.
    Bangalore S; Makani H; Radford M; Thakur K; Toklu B; Katz SD; DiNicolantonio JJ; Devereaux PJ; Alexander KP; Wetterslev J; Messerli FH
    Am J Med; 2014 Oct; 127(10):939-53. PubMed ID: 24927909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Björck L; Wallentin L; Stenestrand U; Lappas G; Rosengren A
    Arch Intern Med; 2010 Aug; 170(15):1375-81. PubMed ID: 20696964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta-blockers in acute myocardial infarction.
    Kumar S; Bandopadhyay S
    Indian Heart J; 2011; 63(1):66-70. PubMed ID: 23189867
    [No Abstract]   [Full Text] [Related]  

  • 48. Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia.
    Keough-Ryan TM; Kiberd BA; Dipchand CS; Cox JL; Rose CL; Thompson KJ; Clase CM
    Am J Kidney Dis; 2005 Nov; 46(5):845-55. PubMed ID: 16253724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular drug therapy in the elderly.
    Aronow WS; Frishman WH; Cheng-Lai A
    Cardiol Rev; 2007; 15(4):195-215. PubMed ID: 17575484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ACC/AHA guidelines on the management of acute myocardial infarction. American College of Cardiology and the American Heart Association.
    Morey SS
    Am Fam Physician; 2000 Mar; 61(6):1901-2, 1904. PubMed ID: 10750884
    [No Abstract]   [Full Text] [Related]  

  • 51. Saving lives after myocardial infarction: the role of beta-adrenergic blockers.
    Frishman WH
    Mt Sinai J Med; 1990 Mar; 57(2):75-84. PubMed ID: 1973260
    [No Abstract]   [Full Text] [Related]  

  • 52. Myocardial salvage: pharmacologic treatment.
    Sanders AB
    Emerg Med Clin North Am; 1988 May; 6(2):361-72. PubMed ID: 2894982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cardioprotective properties of beta-blockers in patients after myocardial infarction].
    Sehayek E; Avni Y; Jedwab M
    Harefuah; 1986 Dec; 111(12):427-30. PubMed ID: 2881852
    [No Abstract]   [Full Text] [Related]  

  • 54. Review of beta blocker myocardial infarction trials.
    Goldstein S
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III54-7. PubMed ID: 2575021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Developments in the treatment of myocardial infarction in Switzerland 1986-1990: results of a population survey].
    Hungerbühler P; Wietlisbach V; Rickenbach M; Vogt P
    Schweiz Med Wochenschr; 1992 Dec; 122(50):1919-26. PubMed ID: 1361242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atherothrombotic insights into secondary prevention after acute myocardial infarction.
    Rabbani LE; Loscalzo J
    Can J Cardiol; 1993 Oct; 9(8):739-47. PubMed ID: 7903593
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Physician characteristics and the initiation of beta-adrenergic blocking agent therapy after acute myocardial infarction in a managed care population.
    Fehrenbach SN; Budnitz DS; Gazmararian JA; Krumholz HM
    Am J Manag Care; 2001 Jul; 7(7):717-23. PubMed ID: 11464429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival among patients receiving beta-blockers after acute myocardial infarction.
    Cheng TO
    Am J Cardiol; 2006 Apr; 97(7):1125. PubMed ID: 16563932
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical outcomes with beta-blockers after myocardial infarction: finding the right patient and the right regimen.
    Jennings DL; Miyares MA
    Am J Med; 2014 Dec; 127(12):e17. PubMed ID: 25481200
    [No Abstract]   [Full Text] [Related]  

  • 60. Beta-blockers and heart attack.
    Harv Health Lett; 1998 Nov; 24(1):8. PubMed ID: 9857852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.